Brief: Hikma Says Buyback Programme Valued At US $250 Million

Hikma Pharmaceuticals

26/02/2026 07:24

Feb 26 (Reuters) - Hikma Pharmaceuticals PLC HIK.L:

HIKMA - COMMENCES BUYBACK PROGRAMME FOR ORDINARY SHARES

HIKMA - BUYBACK PROGRAMME VALUED AT US $250 MILLION

Source text: ID:nRSZ4522Ua

Further company coverage: HIK.L

 (((( Reuters.Briefs@thomsonreuters.com ;));))